Disclosures for "Protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease")
-
Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has received stock or an ownership interest from ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neuroscinces.
-
Judith Silverman has received personal compensation for serving as an employee of Bill & Melinda Gates Foundation.
-
Beibei Zhao has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Coutts has nothing to disclose.
-
Xubiao Peng has nothing to disclose.
-
Steven S. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ProMIS Neurosciences. Steven S. Plotkin has stock in ProMIS Neurosciences. The institution of Steven S. Plotkin has received research support from Canadian Institutes of Health Research. The institution of Steven S. Plotkin has received research support from Digital Technology Supercluster. Steven S. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care. Dr. Cashman has a non-compensated relationship as a BoD memeber with ALS Society of BC that is relevant to AAN interests or activities.